Washington, United States:
The US Food and Drug Administration on Monday up to date its warning labels for the Johnson & Johnson Covid-19 vaccine to incorporate details about an noticed “increased risk” of a uncommon neurological dysfunction.
Based on evaluation of a federal vaccine security monitoring system, officers have recognized 100 preliminary studies of Guillain-Barre Syndrome after roughly 12.5 million doses administered, individuals acquainted with the matter mentioned.
Of these studies, 95 of them have been severe and required hospitalization. There was one reported loss of life.
(THIS STORY HAS NOT BEEN EDITED BY INDIA07 TEAM AND IS AUTO-GENERATED FROM A SYNDICATED FEED.)